Multicenter, cross-sectional study of the economic burden of multiple sclerosis and cost-driving factors
This study highlights MS's economic burden in Algeria, with DMTs as the primary cost driver. Optimized resource allocation and cost-effective DMT strategies are essential to improve MS care.
Authors
- Mohammed Adil Selka (ORCID: https://orcid.org/0000-0003-3060-3809)
- Houari Toumi (ORCID: https://orcid.org/0000-0002-9056-6301)
- Moustafa Berrichi (ORCID: https://orcid.org/0000-0002-7015-4000)
- Zahira Barka-Bedrane
- Ahlam Osmani
- Karima Belahcen
- Bouchra Hafsi
- Ines Messaoudi
Institutions
- Université Oran 1 Ahmed Ben Bella (DZ)
- Dynamic Systems (United States) (US)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1080/14737167.2025.2539840
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47